Proto Labs, Inc.
PRLB
$57.59
$0.250.44%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 136.49M | 135.37M | 135.06M | 126.21M | 121.75M |
| Total Other Revenue | -- | -- | -- | -- | 206.00K |
| Total Revenue | 136.49M | 135.37M | 135.06M | 126.21M | 121.75M |
| Cost of Revenue | 76.12M | 74.07M | 75.29M | 70.51M | 69.79M |
| Gross Profit | 60.37M | 61.29M | 59.77M | 55.70M | 51.96M |
| SG&A Expenses | 42.31M | 41.74M | 43.48M | 40.60M | 38.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 128.75M | 126.52M | 129.95M | 121.71M | 117.66M |
| Operating Income | 7.74M | 8.85M | 5.12M | 4.49M | 4.09M |
| Income Before Tax | 8.15M | 10.25M | 6.67M | 5.99M | -282.00K |
| Income Tax Expenses | 2.15M | 3.04M | 2.25M | 2.39M | 122.00K |
| Earnings from Continuing Operations | 6.00M | 7.22M | 4.43M | 3.60M | -404.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.00M | 7.22M | 4.43M | 3.60M | -404.00K |
| EBIT | 7.74M | 8.85M | 5.12M | 4.49M | 4.09M |
| EBITDA | 16.19M | 17.28M | 13.69M | 13.19M | 13.24M |
| EPS Basic | 0.25 | 0.30 | 0.19 | 0.15 | -0.02 |
| Normalized Basic EPS | 0.24 | 0.27 | 0.18 | 0.15 | 0.14 |
| EPS Diluted | 0.25 | 0.30 | 0.18 | 0.15 | -0.02 |
| Normalized Diluted EPS | 0.24 | 0.27 | 0.18 | 0.15 | 0.14 |
| Average Basic Shares Outstanding | 23.76M | 23.89M | 23.90M | 24.14M | 24.47M |
| Average Diluted Shares Outstanding | 24.17M | 24.19M | 24.10M | 24.44M | 24.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |